4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-18-031810
President and CEO sold 2,028 shares at $25.09 ($50,880)
- President and CEO acquired 2,028 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCarthy Sean A. President and CEO | 2018-07-03 | Option exercise | +2,028 | $1.57 | $3,194 | 84,091 | D |
| McCarthy Sean A. President and CEO | 2018-07-03 | Sale | −2,028 | $25.09 | $50,880 | 82,063 | D |
| Derivatives | |||||||
| McCarthy Sean A. President and CEO | 2018-07-03 | Option exercise · Stock Option (Right to Buy) | −2,028 | 160,146 | D | ||
| Open-market sales · 2,028 sh · avg $25.09 · $50,880 | |||||||
Loading xslF345X03/doc1.xml…